A Narrative Review of the Cases of Co-altered EGFR and ALK in Non-small Cell Lung Cancers: An Attempt to Break the Therapeutic Dilemma
Molecular profiling is essential in advanced non-small cell lung cancer (NSCLC) to identify actionable genetic alterations and guide targeted therapies. While epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements are historically considered mutually exclusive alterations,...